Tatsuro Misu Selected Research

Steroids

5/2022	Exploring steroid tapering in patients with neuromyelitis optica spectrum disorder treated with satralizumab in SAkuraSky: A case series.
3/2021	Myelin oligodendrocyte glycoprotein-IgG-positive, steroid-responsive combined central and peripheral demyelination with recurrent peripheral neuropathy.
1/2021	Optic neuritis after ocular trauma in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
1/2019	Two Japanese cases of anti-MOG antibody-associated encephalitis that mimicked neuro-Behçet's disease.
3/2017	MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy.
12/2014	Audiological evidence of therapeutic effect of steroid treatment in neuromyelitis optica with hearing loss.
1/2012	[Case of recurrent encephalomyelitis associated with eosinophilia in CSF].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tatsuro Misu Research Topics

Disease

48	Neuromyelitis Optica (Devic's Disease) 05/2022 - 04/2004
22	Multiple Sclerosis 01/2022 - 11/2002
13	Optic Neuritis (Retrobulbar Neuritis) 01/2022 - 01/2011
13	Demyelinating Diseases (Demyelinating Disease) 01/2022 - 08/2010
8	Encephalitis (Encephalitis, Rasmussen) 01/2020 - 11/2009
5	Myelitis 03/2021 - 02/2008
5	Leukocytosis (Pleocytosis) 02/2020 - 05/2012
4	Infections 05/2022 - 09/2015
4	Inflammation (Inflammations) 02/2020 - 05/2012
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2015 - 10/2004
3	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 01/2022 - 10/2015
3	Autoimmune Diseases (Autoimmune Disease) 11/2014 - 05/2003
3	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 02/2005 - 08/2003
2	Vision Disorders (Hemeralopia) 01/2022 - 01/2020
2	Fatigue 01/2021 - 06/2015
2	Encephalomyelitis (Myeloencephalitis) 01/2020 - 01/2012
2	Disease Progression 01/2018 - 10/2015
2	Aphasia (Dysphasia) 01/2018 - 09/2014
2	Central Nervous System Diseases (CNS Diseases) 10/2015 - 11/2014
2	Spinal Cord Diseases 03/2015 - 08/2003
2	Necrosis 06/2013 - 10/2004
1	Hepatitis E 05/2022
1	Human Influenza (Influenza) 05/2022
1	Hypesthesia (Numbness) 01/2022
1	COVID-19 01/2022
1	Ganglion Cysts (Ganglion) 01/2022
1	Atrophy 01/2022
1	Abducens Nerve Diseases (Sixth Nerve Palsy) 01/2022
1	Immune System Diseases (Immune Disorders) 05/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 03/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Gliosis 01/2021
1	Uterine Neoplasms (Uterine Cancer) 01/2020
1	Glaucoma 01/2020
1	Diplopia (Double Vision) 01/2020
1	Hemorrhage 01/2020
1	Compression Fractures (Compression Fracture) 01/2020
1	Immune Reconstitution Inflammatory Syndrome 01/2018
1	Paresis (Hemiparesis) 01/2018
1	Progressive Multifocal Leukoencephalopathy 01/2018
1	Paraparesis 01/2017
1	Hypoxia (Hypoxemia) 11/2016
1	Neuroinflammatory Diseases 11/2016
1	Retinitis 01/2016
1	Leukoencephalopathies 09/2015
1	Edema (Dropsy) 09/2015
1	Epilepsy (Aura) 01/2015
1	Temporal Lobe Epilepsy 01/2015
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2015
1	Stiff-Person Syndrome (Stiff Man Syndrome) 01/2015
1	Hearing Loss (Hearing Impairment) 12/2014
1	Pain (Aches) 09/2014
1	Nausea 06/2013
1	Hiccup (Hiccups) 06/2013
1	Vomiting 06/2013

Drug/Important Bio-Agent (IBA)

22	AntibodiesIBA 01/2022 - 11/2009
16	AutoantibodiesIBA 05/2021 - 05/2007
16	Immunoglobulin G (IgG)IBA 03/2021 - 05/2007
11	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022 - 02/2014
11	Aquaporin 4IBA 01/2021 - 11/2010
8	Complement System Proteins (Complement)IBA 05/2021 - 07/2011
7	SteroidsIBA 05/2022 - 01/2012
7	ChemokinesIBA 11/2016 - 08/2003
6	Aquaporins (Water Channels)IBA 01/2020 - 05/2007
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2010
4	Retinaldehyde (Retinal)IBA 01/2022 - 12/2010
4	CytokinesIBA 02/2020 - 10/2004
4	Methylprednisolone FDA LinkGeneric 01/2020 - 05/2008
3	Proteins (Proteins, Gene)FDA Link 03/2017 - 01/2005
3	Therapeutic UsesIBA 12/2014 - 02/2005
3	anti-aquaporin 4 autoantibodyIBA 12/2014 - 05/2008
3	Glial Fibrillary Acidic ProteinIBA 08/2014 - 05/2008
3	InterferonsIBA 10/2012 - 10/2004
3	Interferon-alpha (Interferon Alfa)IBA 02/2005 - 08/2003
2	Rituximab (Mabthera)FDA Link 04/2022 - 01/2020
2	Prednisolone (Predate)FDA LinkGeneric 04/2021 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 08/2014
2	Fingolimod Hydrochloride (FTY720)FDA Link 01/2018 - 03/2014
2	Myelin Basic ProteinIBA 03/2017 - 05/2012
2	Monoclonal AntibodiesIBA 01/2016 - 12/2015
2	Oligoclonal BandsIBA 01/2011 - 06/2004
2	AntigensIBA 01/2011 - 05/2007
1	satralizumabIBA 05/2022
1	Atrial Natriuretic Factor (ANF)IBA 01/2022
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2021
1	Myelin-Associated GlycoproteinIBA 01/2021
1	eculizumab FDA Link 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019
1	HLA-B51 AntigenIBA 01/2019
1	Glutamate Receptors (Glutamate Receptor)IBA 03/2017
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 03/2017
1	Carnitine (L-Carnitine)FDA LinkGeneric 06/2015
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2015
1	Interleukin-1beta (Interleukin 1 beta)IBA 05/2013

Therapy/Procedure

11	Therapeutics 04/2021 - 06/2004
2	Plasma Exchange 04/2012 - 05/2007
1	Secondary Prevention 01/2021